Clinical Trial Update: "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"

View source ↗

Summary

A clinical trial update examining the incidence and consequences of disorders of glycosylation in patients with conotruncal and septal heart defects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Iii Deficiency
• Atrial Septal Defect
• Congenital Disorder of Glycosylation
• Congenital Heart Disease
• Conotruncal Defect
• Ventricular Septal Defect

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Congenital Heart Diseases, Conotruncal Defects | Status: UNKNOWN